Page last updated: 2024-08-22

magnesium sulfate and Leukomalacia, Periventricular

magnesium sulfate has been researched along with Leukomalacia, Periventricular in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (28.57)18.2507
2000's4 (28.57)29.6817
2010's5 (35.71)24.3611
2020's1 (7.14)2.80

Authors

AuthorsStudies
Beltempo, M; Bertelle, V; Boucorian, I; Dahlgren, L; Lemyre, B; Pelausa, E; Rizzolo, A; Shah, PS; St Hilaire, M1
Bhutada, A; Brown, A; Egbert, NM; Haberman, S; Minkoff, H; Narasimhulu, D; Rastogi, S; Rojas, M1
Asou, H; Fujii, T; Ichinose, M; Imada, S; Iriyama, T; Kamei, Y; Seyama, T; Toshimitsu, M1
Ancel, PY; Benhammou, V; d'Ercole, C; Delorme, P; Foix-L'Hélias, L; Gire, C; Goffinet, F; Kayem, G; Lorthe, E; Marchand-Martin, L; Sentilhes, L; Subtil, D; Torchin, H; Winer, N1
Bulas, D; Caritis, SN; Carpenter, MW; DiPietro, M; Dudley, D; Hankins, GD; Hirtz, DG; Iams, JD; Malone, FD; Mercer, BM; O'Sullivan, MJ; Peaceman, AM; Ramin, SM; Reddy, UM; Rouse, DJ; Seibert, J; Sorokin, Y; Thorp, JM; Varner, MW; Wapner, RJ; Weiner, SJ1
Matsuda, Y; Mitani, M; Shimada, E1
Itakura, A; Matsuzawa, K; Mizutani, S; Murata, Y; Okumura, A; Wakai, K1
Bénichou, J; Eurin, D; Hellot, MF; Lévêque, C; Marpeau, L; Marret, S; Zupan-Simunek, V1
Astruc, D; Bénichou, J; Bruel, H; Cambonie, G; Delaporte, B; Follet-Bouhamed, C; Guillois, B; Marpeau, L; Marret, S; Pinquier, D; Zupan-Simunek, V1
Allred, EN; Hegyi, T; Hiatt, M; Kuban, K; Leviton, A; Paneth, N; Reuss, ML; Sanocka, U; Shahrivar, F; Susser, M; Van Marter, LJ1
FineSmith, RB; Fish, I; Kahn, A; Roche, K; Shen, C; Walsh, KK; Yellin, PB; Zeglis, M1
Volpe, JJ1
Canterino, JC; Figueroa, R; Klein, SA; Tejani, NA; Verma, UL; Visintainer, PF1
Besinger, RE; Dambrosia, J; Gianopoulos, JG; Lee, KS; Mittendorf, R; Pryde, PG; Tomich, PG1

Reviews

1 review(s) available for magnesium sulfate and Leukomalacia, Periventricular

ArticleYear
Brain injury in the premature infant. Neuropathology, clinical aspects, pathogenesis, and prevention.
    Clinics in perinatology, 1997, Volume: 24, Issue:3

    Topics: Brain Diseases; Cell Death; Cerebral Hemorrhage; Cerebral Infarction; Cerebrovascular Circulation; Free Radical Scavengers; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Leukomalacia, Periventricular; Magnesium Sulfate; Oligodendroglia; Spectroscopy, Near-Infrared; Tocolytic Agents

1997

Trials

5 trial(s) available for magnesium sulfate and Leukomalacia, Periventricular

ArticleYear
Antenatal Magnesium and Cerebral Palsy in Preterm Infants.
    The Journal of pediatrics, 2015, Volume: 167, Issue:4

    Topics: Cerebral Hemorrhage; Cerebral Palsy; Cerebral Ventricles; Child, Preschool; Cohort Studies; Electroencephalography; Female; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Leukomalacia, Periventricular; Magnesium Sulfate; Male; Maternal Exposure; Neuroprotective Agents; Pregnancy; Ultrasonography

2015
Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial*.
    BJOG : an international journal of obstetrics and gynaecology, 2007, Volume: 114, Issue:3

    Topics: Adult; Cerebral Palsy; Female; Humans; Infant Mortality; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Leukomalacia, Periventricular; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Tocolytic Agents

2007
[Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial].
    Gynecologie, obstetrique & fertilite, 2008, Volume: 36, Issue:3

    Topics: Adult; Cerebral Palsy; Female; Humans; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Leukomalacia, Periventricular; Longitudinal Studies; Magnesium Sulfate; Male; Morbidity; Nervous System Diseases; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Prospective Studies; Tocolytic Agents; Treatment Outcome

2008
Effect of magnesium sulfate on the development of cystic periventricular leukomalacia in preterm infants.
    American journal of perinatology, 1997, Volume: 14, Issue:5

    Topics: Anticonvulsants; Birth Weight; Cysts; Female; Humans; Infant, Newborn; Infant, Premature; Leukomalacia, Periventricular; Magnesium Sulfate; Pre-Eclampsia; Predictive Value of Tests; Pregnancy; Retrospective Studies; Risk Factors

1997
Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.
    American journal of obstetrics and gynecology, 2002, Volume: 186, Issue:6

    Topics: Adult; Cerebral Hemorrhage; Cerebral Palsy; Female; Fetal Blood; Humans; Infant Mortality; Infant, Newborn; Labor, Obstetric; Leukomalacia, Periventricular; Magnesium; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Prenatal Care; Risk Factors; Tocolytic Agents

2002

Other Studies

8 other study(ies) available for magnesium sulfate and Leukomalacia, Periventricular

ArticleYear
Cumulative effect of evidence-based practices on outcomes of preterm infants born at <29 weeks' gestational age.
    American journal of obstetrics and gynecology, 2020, Volume: 222, Issue:2

    Topics: Adrenal Cortex Hormones; Anticonvulsants; Body Temperature; Canada; Cerebral Intraventricular Hemorrhage; Constriction; Evidence-Based Medicine; Female; Humans; Infant, Extremely Premature; Infant, Newborn; Leukomalacia, Periventricular; Logistic Models; Magnesium Sulfate; Male; Multivariate Analysis; Perinatal Death; Pregnancy; Prenatal Care; Retrospective Studies; Severity of Illness Index; Time Factors; Umbilical Cord

2020
Maternal magnesium therapy, neonatal serum magnesium concentration and immediate neonatal outcomes.
    Journal of perinatology : official journal of the California Perinatal Association, 2017, Volume: 37, Issue:12

    Topics: Adult; Case-Control Studies; Cerebral Intraventricular Hemorrhage; Dose-Response Relationship, Drug; Female; Gestational Age; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infusions, Intravenous; Leukomalacia, Periventricular; Magnesium; Magnesium Sulfate; Male; Neuroprotective Agents; Pregnancy; Retrospective Studies; Tocolytic Agents; Young Adult

2017
Pretreatment with magnesium sulfate attenuates white matter damage by preventing cell death of developing oligodendrocytes.
    The journal of obstetrics and gynaecology research, 2018, Volume: 44, Issue:4

    Topics: Animals; Cell Death; Disease Models, Animal; Hypoxia-Ischemia, Brain; Leukomalacia, Periventricular; Magnesium Sulfate; Male; Neuroprotective Agents; Oligodendroglia; Rats; Rats, Sprague-Dawley; White Matter

2018
Preterm premature rupture of membranes at 22-25 weeks' gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2).
    American journal of obstetrics and gynecology, 2018, Volume: 219, Issue:3

    Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Cerebral Intraventricular Hemorrhage; Cerebral Palsy; Cesarean Section; Child, Preschool; Enterocolitis, Necrotizing; Female; Fetal Membranes, Premature Rupture; Fetal Mortality; Fetal Viability; France; Gestational Age; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Labor, Obstetric; Leukomalacia, Periventricular; Magnesium Sulfate; Patient Transfer; Perinatal Mortality; Pregnancy; Pregnancy Trimester, Second; Prenatal Care; Retinopathy of Prematurity; Stillbirth; Survival Rate; Tocolysis; Tocolytic Agents

2018
Short- and long-term outcomes in babies born after antenatal magnesium treatment.
    The journal of obstetrics and gynaecology research, 2011, Volume: 37, Issue:11

    Topics: Case-Control Studies; Cerebral Hemorrhage; Cerebral Palsy; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Leukomalacia, Periventricular; Magnesium Sulfate; Pregnancy; Pregnancy Outcome; Tocolysis; Tocolytic Agents; Treatment Outcome

2011
Possible antenatal and perinatal related factors in development of cystic periventricular leukomalacia.
    Brain & development, 2005, Volume: 27, Issue:1

    Topics: Apgar Score; Case-Control Studies; Causality; Cerebral Palsy; Chorioamnionitis; Comorbidity; Female; Gestational Age; Humans; Indomethacin; Infant, Newborn; Leukomalacia, Periventricular; Magnesium Sulfate; Multivariate Analysis; Pre-Eclampsia; Pregnancy; Premature Birth; Prenatal Exposure Delayed Effects; Retrospective Studies; Risk Assessment; Umbilical Cord

2005
Maternal receipt of magnesium sulfate does not seem to reduce the risk of neonatal white matter damage.
    Pediatrics, 1997, Volume: 99, Issue:4

    Topics: Adrenal Cortex Hormones; Brain; Cerebral Hemorrhage; Cerebral Palsy; Confounding Factors, Epidemiologic; Echoencephalography; Female; Humans; Hypertension; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Leukomalacia, Periventricular; Logistic Models; Magnesium Sulfate; Odds Ratio; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies

1997
Maternal magnesium sulfate and the development of neonatal periventricular leucomalacia and intraventricular hemorrhage.
    Obstetrics and gynecology, 1999, Volume: 93, Issue:3

    Topics: Anticonvulsants; Cerebral Hemorrhage; Female; Humans; Incidence; Infant, Newborn; Infant, Premature, Diseases; Leukomalacia, Periventricular; Magnesium Sulfate; Pregnancy; Pregnancy Complications; Retrospective Studies; Severity of Illness Index; Tocolytic Agents

1999